These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 2257144)

  • 1. A new cellular model of response to estrogens: a bioluminescent test to characterize (anti) estrogen molecules.
    Pons M; Gagne D; Nicolas JC; Mehtali M
    Biotechniques; 1990 Oct; 9(4):450-9. PubMed ID: 2257144
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Screening for estrogenicity and anti-estrogenicity: a critical evaluation of an MVLN cell-based transactivation assay.
    Freyberger A; Schmuck G
    Toxicol Lett; 2005 Jan; 155(1):1-13. PubMed ID: 15585354
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Overexpression of estrogen receptor in HTB 96 human osteosarcoma cells results in estrogen-induced growth inhibition and receptor cross talk.
    Watts CK; King RJ
    J Bone Miner Res; 1994 Aug; 9(8):1251-8. PubMed ID: 7976507
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An estrogen-responsive element-targeted histone deacetylase enzyme has an antiestrogen activity that differs from that of hydroxytamoxifen.
    Demirpence E; Semlali A; Oliva J; Balaguer P; Badia E; Duchesne MJ; Nicolas JC; Pons M
    Cancer Res; 2002 Nov; 62(22):6519-28. PubMed ID: 12438246
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dehydroepiandrosterone sulfate estrogenic action at its physiological plasma concentration in human breast cancer cell lines.
    Le Bail JC; Allen K; Nicolas JC; Habrioux G
    Anticancer Res; 1998; 18(3A):1683-8. PubMed ID: 9673390
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hydroxytamoxifen induces a rapid and irreversible inactivation of an estrogenic response in an MCF-7-derived cell line.
    Badia E; Duchesne MJ; Fournier-Bidoz S; Simar-Blanchet AE; Terouanne B; Nicolas JC; Pons M
    Cancer Res; 1994 Nov; 54(22):5860-6. PubMed ID: 7954415
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A rapid and sensitive high throughput reporter gene assay for estrogenic effects of environmental contaminants.
    Edmunds JS; Fairey ER; Ramsdell JS
    Neurotoxicology; 1997; 18(2):525-32. PubMed ID: 9291500
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Stable luciferase transfected cells for studying steroid receptor biological activity.
    Gagne D; Balaguer P; Demirpence E; Chabret C; Trousse F; Nicolas JC; Pons M
    J Biolumin Chemilumin; 1994; 9(3):201-9. PubMed ID: 7942125
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vivo bioluminescence imaging to evaluate estrogenic activities of endocrine disrupters.
    Pillon A; Servant N; Vignon F; Balaguer P; Nicolas JC
    Anal Biochem; 2005 May; 340(2):295-302. PubMed ID: 15840503
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of tumor-associated fatty acid synthase activity antagonizes estradiol- and tamoxifen-induced agonist transactivation of estrogen receptor (ER) in human endometrial adenocarcinoma cells.
    Menendez JA; Oza BP; Atlas E; Verma VA; Mehmi I; Lupu R
    Oncogene; 2004 Jun; 23(28):4945-58. PubMed ID: 15094777
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MVLN cells: a bioluminescent MCE-7-derived cell line to study the modulation of estrogenic activity.
    Demirpence E; Duchesne MJ; Badia E; Gagne D; Pons M
    J Steroid Biochem Mol Biol; 1993 Sep; 46(3):355-64. PubMed ID: 9831484
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Activity of estradiol and selective estrogen receptor modulators in the mouse N20.1 oligodendrocyte/astrocytes cell line.
    Guzmán CB; Deighton-Collins S; Martinez A; Kleerekoper M; Zhao C; Benjamins JA; Skafar DF
    Neuro Endocrinol Lett; 2005 Oct; 26(5):526-32. PubMed ID: 16264406
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Steroidal affinity labels of the estrogen receptor. 3. Estradiol 11 beta-n-alkyl derivatives bearing a terminal electrophilic group: antiestrogenic and cytotoxic properties.
    Lobaccaro C; Pons JF; Duchesne MJ; Auzou G; Pons M; Nique F; Teutsch G; Borgna JL
    J Med Chem; 1997 Jul; 40(14):2217-27. PubMed ID: 9216841
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prenylation inhibitors stimulate both estrogen receptor alpha transcriptional activity through AF-1 and AF-2 and estrogen receptor beta transcriptional activity.
    Cestac P; Sarrabayrouse G; Médale-Giamarchi C; Rochaix P; Balaguer P; Favre G; Faye JC; Doisneau-Sixou S
    Breast Cancer Res; 2005; 7(1):R60-70. PubMed ID: 15642170
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antiestrogenic activity of hydroxylated polychlorinated biphenyl congeners identified in human serum.
    Moore M; Mustain M; Daniel K; Chen I; Safe S; Zacharewski T; Gillesby B; Joyeux A; Balaguer P
    Toxicol Appl Pharmacol; 1997 Jan; 142(1):160-8. PubMed ID: 9007045
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Induction of aromatase (CYP19) expression in breast cancer cells through a nongenomic action of estrogen receptor alpha.
    Kinoshita Y; Chen S
    Cancer Res; 2003 Jul; 63(13):3546-55. PubMed ID: 12839940
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transcriptional regulation of vascular endothelial growth factor by estradiol and tamoxifen in breast cancer cells: a complex interplay between estrogen receptors alpha and beta.
    Buteau-Lozano H; Ancelin M; Lardeux B; Milanini J; Perrot-Applanat M
    Cancer Res; 2002 Sep; 62(17):4977-84. PubMed ID: 12208749
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recombinant cell bioassays for endocrine disruptors: development of a stably transfected human ovarian cell line for the detection of estrogenic and anti-estrogenic chemicals.
    Rogers JM; Denison MS
    In Vitr Mol Toxicol; 2000; 13(1):67-82. PubMed ID: 10900408
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Antiestrogenic effect of retinoic acid in MCF-7 cells].
    Demirpence E; Pons M; Balaguer P; Gagne D
    C R Seances Soc Biol Fil; 1991; 185(6):444-55. PubMed ID: 1822393
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MAP kinase/estrogen receptor cross-talk enhances estrogen-mediated signaling and tumor growth but does not confer tamoxifen resistance.
    Atanaskova N; Keshamouni VG; Krueger JS; Schwartz JA; Miller F; Reddy KB
    Oncogene; 2002 Jun; 21(25):4000-8. PubMed ID: 12037682
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.